# DESCRIPTION

## STATEMENT OF GOVERNMENT INTEREST

- disclose government support

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND

- introduce quorum sensing
- describe quorum sensing process
- explain QS in pathogenic bacteria
- discuss QS in V. cholerae
- motivate QS potentiators as drugs
- describe QS autoinducer molecules
- explain QS detection mechanism
- describe QS circuitry
- discuss targeting response regulators
- summarize inhibitors of response regulators
- discuss challenges in developing TCS inhibitors

## SUMMARY OF THE INVENTION

- disclose novel strategies for QS activation
- describe virulence inhibitor molecules
- explain strategies for developing anti-infectives
- describe compounds for QS activation
- outline method for inhibiting virulence
- summarize methods for prophylactic treatment and biofilm inhibition

## DETAILED DESCRIPTION OF THE INVENTION

- identify QS-activating molecules
- classify QS-activating molecules
- describe LuxO inhibitors
- analyze genetic mutants
- show broad activation of vibrio QS circuits
- discuss use of pro-QS agents to treat infections
- describe LuxO inhibitors as prophylactics
- contemplate use of LuxO inhibitors as NtrC-type response regulator inhibitors
- discuss potential for developing inhibitors of AAA+ ATPases

### Materials and Methods

- describe bacterial strains and culture conditions
- provide genotypes of plasmids and strains
- describe screening for V. cholerae QS-activating molecules
- describe bioluminescence assays for V. cholerae and V. harveyi
- describe protein purification
- describe ATPase assays
- describe DNA binding assays
- describe screening for LuxO mutants resistant to inhibitors
- describe Western blot analysis
- describe cytotoxicity assays
- describe analytical methods
- describe NMR spectroscopy
- describe high-resolution mass spectral analysis
- describe materials used
- describe methods used
- provide references for methods

### Chemical Reactions.

- introduce reaction conditions
- describe purification methods
- outline compound synthesis general procedure
- synthesize neopentyl 2-((3,5-dioxo-2,3,4,5-tetrahydro-1
- synthesize isobutyl 2-((3,5-dioxo-2,3,4,5-tetrahydro-1
- synthesize cyclobutylmethyl 2-((3,5-dioxo-2,3,4,5-tetrahydro
- synthesize cyclopropylmethyl 2-((3,5-dioxo-2,3,4,5-tetrahydro
- synthesize 3-methylbutan-2-yl 2-((3,5-dioxo-2,3,4,5
- synthesize (trimethylsilyl)methyl 2-((3,5-dioxo-2,3,4,5
- synthesize 3,3-dimethylbutan-2-yl 2-((3,5-dioxo-2,3,
- synthesize 2-((3,5-dioxo-2,3,4,5-tetrahydro-1,2,4

## Results

- identify molecules that activate QS in V. cholerae
- investigate targets of QS activating compounds
- analyze structure-activity-relationship of Class 2 compounds

### Investigation of the Targets of the QS Activating Compounds

- test Class 1 compounds against V. cholerae mutants
- investigate Class 2 compounds that activate QS in both LCD screening strains
- determine which QS component each compound acts on

### Structure-Activity-Relationship of Class 2 Compounds

- synthesize a focused library of compounds bearing the conserved 5-thio-6-azauracil core
- measure activities using bioluminescence in the V. cholerae luxOD47E mutant

### Class 2 Compounds Inhibit the LuxO ATPase Activity

- investigate which LuxO activities are inhibited by compounds 11 and 12
- use whole-cell bioluminescence assays to test LuxO activities
- examine LuxO binding to DNA using electrophoretic-mobility-shift and fluorescence anisotropy assays
- assess LuxO ATPase activity using a coupled-enzyme assay
- analyze inhibition of LuxO ATPase by compounds 11 and 12

### A Genetic Screen to Identify LuxO Mutants Resistant to Compound 12

- engineer random mutations into the cloned luxOD47E gene
- screen for LuxO mutants refractory to inhibition

### Broad Spectrum Activation of Vibrio QS

- test compounds 11 and 12 to determine if they can activate QS in other Vibrio species
- exploit two well-characterized phenotypes controlled by QS
- conclude that the LuxO inhibitors are broadly capable of activating QS in Vibrio species

### New Chemical Tools for Controlling Virulence in Vibrios

- test whether the inhibitors can disrupt the QS-controlled virulence outputs of pathogenic vibrios
- assay effects on TcpA production in V. cholerae
- assay effects on production and secretion of VopD in V. parahaemolyticus
- test whether repression of in vitro virulence phenotype translates to repression of in vivo phenotype
- conclude that the LuxO inhibitors have the potential to be anti-virulence agents

## Discussion Of Results

- summarize the identification of two classes of molecules that activate QS in V. cholerae
- discuss the potential of the molecules as novel chemical probes
- discuss the potential of the molecules as anti-virulence agents
- analyze the Class 1 molecules that act on the V. cholerae CqsS receptor
- discuss the Class 2 molecules that act on LuxO
- analyze the mechanism of LuxO inhibition
- discuss the identification of LuxO inhibitor-resistant mutants
- analyze the binding site of the LuxO inhibitors
- discuss the potential for developing general inhibitors of NtrC-family proteins
- conclude that targeting the ATPase domain offers an additional route for anti-TCS drug development

